Year established: 2000
Points of interest:
- The ISRCTN is a freely accessible and searchable primary clinical trial registry that accepts proposed, ongoing, or completed clinical trials
- The ISRCTN complies with international guidelines and pools its data in the International Trial Search Portal initiated by the World Health Organization, and it is recognized by the ICMJE
- Any study designed to assess the efficacy of health interventions in a human population, including both observational and interventional trials, is covered by the ISRCTN.
- The ISRCTN is controlled by its Board of Directors, who delegate day-to-day management of the registry and database to the editorial team, with additional advice from an international advisory group
- The main purpose of the ISRCTN is to register clinical trials, assign each trial with a unique identifying number, and make records publicly accessible
- The ISRCTN is the preferred partner of the United Kingdom’s Department of Health
- It is never too early or too late to register a study on ISRCTN, but it is suggested to register before patient enrollment begins
- The ISRCTN registry is administered and published by BioMed Central, owned by Springer Nature, located near Regent’s Canal in London
- This registry is not funded by governmental grants and those registering will incur a fee to assist in funding the ISRCTN; payment details can be found here: https://www.isrctn.com/page/faqs#payment
Related transparency research/articles:
- Keeping up with the ISRCTN registry: How much do you know about trial registration?
- World Health Organization ISRCTN overview
- The ISRCTN Register: achievements and challenges 8 years on
TrialAssure® Registry can automate the disclosure of clinical trial results for the International Standard Registered Clinical/Social Study Number Registry (ISRCTN). For questions or a free demo, fill out this form.